Workflow
多元支付
icon
Search documents
让现金支付不再“碰壁” 央行等三部门发布新规为你“撑腰”
Jin Rong Shi Bao· 2025-12-22 05:02
早餐摊前,李大爷掏出叠得整齐的零钱想买两根油条,却被店主摆手说"只接受扫码";社区缴费窗口, 王阿姨攥着退休金存折取出的现金想交物业费,却被告知"现金不受理"——生活中这些让人无奈的现金 支付尴尬,今后将有明确制度"撑腰"。近日,中国人民银行会同国家发展改革委、金融监管总局制定了 《人民币现金收付及服务规定》(以下简称《规定》),构建多元支付方式共同发展下的现金便利流通 环境。 人民币是我国的法定货币,人民币现金作为最基础的支付工具,在服务实体经济、实现普惠金融、维护 金融稳定等方面发挥着重要兜底作用。近年来,尽管"拒收现金违法"的观念已逐渐深入人心,相关投诉 显著减少,但是经营主体收现意愿下降具有一定普遍性、趋势性,拒收现金行为仍难完全杜绝。 四是坚持协同治理。坚持共建共治共享,发挥多部门整治拒收现金会商机制作用,统一政策共识,明确 政策标准,强化部门联动,确保各领域保持现金支付渠道通畅。 《规定》正是在这一背景下应运而生。业内人士认为,《规定》旨在进一步明确各类收费单位、经营主 体以及银行业金融机构的现金服务义务,引导规范各相关主体共同建设和维护人民币现金流通使用环 境,保障整治拒收现金与优化现金使用环境 ...
前8个月健康险保费收入达7599亿元 财险公司保费增速快于人身险公司
Zheng Quan Ri Bao Wang· 2025-09-30 07:53
Core Insights - The health insurance premium income for life insurance companies reached 578.4 billion yuan, a year-on-year increase of 0.5%, while property insurance companies reported 181.5 billion yuan, a growth of 8.9%, leading to a total health insurance premium income of 759.9 billion yuan, up 2.4% year-on-year [1][2] Group 1: Market Trends - The growth rate of health insurance premiums has slowed to 2.4% in the first eight months of the year, attributed to consumer tendencies to cut non-essential spending, product homogeneity, and competition from public health insurance [2][3] - The disparity in growth rates between life and property insurance companies is notable, with property insurance companies showing a higher growth rate due to their focus on short-term products and innovative offerings [3] Group 2: Long-term Potential - Experts remain optimistic about the long-term growth potential of health insurance, driven by factors such as an aging population and increasing health awareness among residents [3][4] - The integration of commercial health insurance into a multi-payment system is encouraged by policies, providing opportunities for product innovation and industry collaboration [3][4] Group 3: Role of Multi-Payment Platforms - Multi-payment platforms, such as Shanghai Meixin Health Technology Group, are enhancing the efficiency and value of health insurance services through innovative payment models and comprehensive service systems [4][5] - These platforms are crucial in connecting medical, pharmaceutical, and insurance sectors, reflecting the ongoing development of the "medical insurance" ecosystem [4][5] Group 4: Industry Development - The growth of multi-payment platforms supports the healthy development of both the insurance and pharmaceutical industries by filling coverage gaps and improving patient payment capabilities [5][6] - These platforms are becoming essential links in enhancing the accessibility of innovative medical products and improving the overall healthcare experience for patients [6]
河北雄安,满足辖区群体的多元支付需求
Jin Rong Shi Bao· 2025-09-05 02:06
Core Insights - The People's Bank of China (PBOC) Xiong'an New Area branch focuses on diverse payment needs of foreign personnel, the elderly, and urban-rural residents since last year [1] - The bank actively guides local financial institutions to promote the coordinated development of mobile payments, bank cards, and cash [1] - Financial services are enhancing the development transformation of the future city by providing convenient payment experiences for foreign personnel and age-friendly services for the elderly [1]
12306App上线京东支付和白条,打造出行多元支付方式
Zhong Jin Zai Xian· 2025-08-08 08:35
Group 1 - The core viewpoint of the news is the collaboration between JD Pay and the 12306 App, which introduces diverse and convenient payment options for travelers during the peak summer travel season [1][2] - JD Pay offers a special discount of up to 27 yuan for train ticket purchases made through the 12306 App, enhancing the user experience and encouraging more travelers to use this payment method [1][2] - The 12306 platform has achieved significant scale, with over 800 million registered users and peak daily traffic reaching 50 billion visits, making it the highest-traffic ticketing platform globally [1] Group 2 - The partnership aims to gradually integrate more JD services and benefits into the 12306 App, contributing to the high-quality development of the railway sector and providing enhanced financial services for JD's over 600 million users [2]
上海医保政策利好,非集采冠脉支架产品入院通道开启
Core Viewpoint - The recent announcement by the Shanghai Medical Insurance Bureau regarding the adjustment of coronary stent reimbursement standards is expected to provide new ideas for diversified payment methods in the industry [1][5]. Group 1: Policy Changes - The new reimbursement rules categorize coronary stents into three payment categories: full reimbursement for selected products, a reduced maximum payment for non-selected products, and a percentage payment for products outside the selection [1][5]. - The policy aims to create a competitive environment for high-value innovative devices alongside selected products, potentially increasing their market presence [1][5]. Group 2: Market Impact - The shift in policy is seen as beneficial for non-selected products, allowing hospitals more freedom to use them after fulfilling procurement obligations for selected products [2][5]. - The coronary stent market has experienced significant price reductions due to centralized procurement, with average prices dropping from approximately 13,000 yuan to around 700 yuan [3][4]. Group 3: Industry Dynamics - The coronary intervention medical device sector is highly competitive, with domestic and international companies vying for market share through technological advancements and product offerings [6][7]. - Companies like Sientra have reported substantial growth in sales of their stent products, indicating a positive response to the new procurement policies [6][7]. Group 4: Future Outlook - The industry is expected to focus on innovation and international expansion as key strategies for growth, with companies exploring new business models and enhancing product lines [7][8]. - The global medical device market is substantial, with opportunities for Chinese companies to expand their presence internationally, driven by policy adjustments and technological advancements [8].